The pivotal Phase 2 trial (NCT04881760), published in The New England Journal of Medicine (Jastreboff et al., 2023), enrolled 338 adults with BMI 30 or higher
Glucocorticoid signaling in the brain increases MAO-A mRNA levels, with SIRT1/NHLH2/ MAO-A pathways driving anxiety-like behavior
Authentic product received
It is approved only in Russia and is not FDA-approved in the US
Generally, higher levels of glutathione are associated with better cellular health, improved detoxification, and a stronger immune system
This therapy makes sense for people who want cleaner energy turnover: the founder cycling through long workdays and late-night workouts, the patient on GLP-1s who feels sluggish as calories shift, or the lifter trying to maintain performance while cutting